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tion assignment. The higher the “c” the smaller the sample to
receive intervention but it is expected that the cost-effectiveness
ratio would be higher. RESULTS: A simulated data set repre-
senting a 10-year study is generated with three predictors includ-
ing a risk factor “R” as well as an outcome “D” and time to
event. A logistic regression model was estimated to predict prob-
abilities used as inputs to a ﬁxed cost per event Markov model.
Selection of sample to receive intervention used hazard ISOBARS
as cutpoints and is compared to selection based on simple risk
factor cut points. ISOBARS for c = 0, 1, . . . 4 were used. It is
useful to note that when c = 0, “e” to the c equals one and splits
the sample into those above average risk and those below
average risk. Intervention assignment based on risk alone used
break points of top 50th, 25th and 10th percentile. CONCLU-
SIONS: Hazard ISOBAR cutpoints for interventions yielded
larger cost-effectiveness ratios than those generated by risk cut-
points alone.
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OBJECTIVE: Clinical trials conducted in multiple countries face
a major analytical hurdle in terms of accounting for costs. The
problem stems from the difference in currency units. Studies that
attempt to analyze these trial results either report the cost-
effectiveness ratios and incremental cost-effectiveness ratios for
each country separately, or opt to use one major currency as a
common denominator. This study offers to measure an incre-
mental cost-effectiveness elasticity (ICEE) as a methodological
approach for aggregation of costs and outcomes information
from Multicenter studies. METHODS: In economics, the notion
of elasticity is used to measure responsiveness of an endogenous
variable with respect to the change in an exogenous variable.
This responsiveness can be calculated using the notion of slope.
However, unlike the slope, which takes into account the unit of
measurement, the elasticity, which measures percentage change
in the endogenous variable per percentage change in the exoge-
nous variables, is unit-free. In analyzing Multicenter clinical trial
data, the measurement of incremental cost-effectiveness ratios
faces similar challenges and results are not comparable across
countries. To get around this measurement problem, the notion
of ICEE is used in this study. RESULTS: Using data published
from Advair cost-effectiveness studies, it is shown that control-
ling for inﬂation, an incremental expenditure of 1% on Advair,
yields an increase in episode-free-days and symptom-free-days by
12.42 % and 9.77%, respectively, compared with competitor
drugs. There was no loss of generality in the interpretation of
the responsiveness of the effects with respect to the costs. CON-
CLUSIONS: ICEE calculated across multiple centers show 
that the results are comparable with the incremental cost-
effectiveness ratios. This methodology could allow comparison
of cost-effectiveness studies across centers without resorting to
currency conversion. This methodology should therefore be used
in lieu of the incremental cost-effectiveness ratios.
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OBJECTIVES: This paper provides a systematic treatment of the
correction for nonrandom sample selection bias of medical cost
data where the selection rule is described by a censored regres-
sion model. METHODS: The proposed method ﬁrst uses the
duration of time a patient is tracked for the selection, rather than
a binary variable, namely whether or not the duration is cen-
sored. Second, using Tobit residuals instead of the inverse Mills
Ratio allows us to decrease large variances introduced by the
Heckman model when there a no exclusion restrictions.
RESULTS: We show that the resulting estimators are consistent
and asymptotically normal. Simulation studies conﬁrmed our
results. Moreover, we derive a simple test to determine possible
sample selection bias due to censoring. Data from a study on the
medical cost of cancer is used as an application of the method.
CONCLUSIONS: We applied OLS, Heckit, Lin[2000],
Lin[2003] methods as well as our proposed method to see how
they would differ in practice. Lin’s methods and the proposed
method were most efﬁcient relative to other methods. In addi-
tion, an advantage of our method was a test of whether selec-
tion bias exists in our data set.
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OBJECTIVES: The objective of this paper is to explain and illus-
trate the usefulness and limitations of bootstrapping method-
ologies and to improve applied health economics research 
by encouraging researchers to rely on rigorous empirical tests
when selecting the most appropriate bootstrapping method.
METHODS: Pair, parametric, nonparametric, and wild boot-
strapping types are analyzed for linear, non linear, instrumental
variable (IV) and discrete choice models. For each model, guide-
lines for selecting a consistent and efﬁcient bootstrapping
method are provided, and percentage deviations from the other
methods are calculated. The Medstat MarketScan® Research
Databases for 1995–2000 were used in this study. Patients with
evidence of asthma were selected from claims, encounter, enroll-
ment, and pharmaceutical data ﬁles. Separate models were esti-
mated for patients in fee-for-service (FFS) and non-FFS plans
based on likelihood tests. Total cost was estimated using linear,
non linear, and IV approaches. The ratio of controller to reliever
medication was used as an IV. Hospitalization was estimated
using a discrete-choice model. Control variables included demo-
graphics, clinical, and county characteristics. RESULTS: We
found that the selection of an inappropriate bootstrapping
methodology can yield results that deviate greatly from the
results produced using the appropriate methodology. Increase in
bias in the estimation of standard errors affects the signiﬁcance
of the coefﬁcients. CONCLUSIONS: There is no single boot-
strapping method that can be applied in all situations since 
the behavior of the bootstrap depends critically on both the 
statistic being examined and approximation to the underlying
population distribution function. In our example, the greatest
deviance was attained between parametric residual bootstrap-
ping and consistent and efﬁcient wild bootstrapping when errors
are heteroskedastic and not normal for estimation of non-linear
model.
